San Diego-based mostly Viking Therapeutics marked alone as a serious competitor inside the weight loss drug sector in February soon after revealing promising facts from the mid-stage demo of experimental drug VK2735, which advised it rivaled—and outperformed—Novo and Lilly drugs when specified for a weekly injection As well as in March the comp